Skip to main content
. 2017 Jun 15;2(12):e93042. doi: 10.1172/jci.insight.93042

Figure 3. Contribution of DI/II– and DIII–specific antibody to overall neutralization.

Figure 3

Comparison of plasma neutralization before and after absorption with yeast clones expressing ZIKV DI/II (A) or DIII (B). The percent contribution was indicated in dark gray, which was calculated by comparing the neutralizing activity of plasma samples that treated with ZIKV DI/II or DIII and irrelevant CD20 yeast clones.